Elicio Therapeutics, Inc.

Historical 13F Holders

Symbol
ELTX
CUSIP
28657F103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 28657F103 since 12/18/2024, newest first.

Filer % of Class Filed
Moti Investments LLC 13G 6.1% 7/16/2026
Event 7/1/2026
Knoll Capital Management, LLC 13G/A Amendment 1
5.3% 7/8/2026
Event 7/1/2026
Actyus Private Equity SGIIC, S.A. 13G/A Amendment 2 1.6% 10/7/2025
Event 9/30/2025
GKCC, LLC 13D/A Amendment 6
48.0% 6/4/2025
Event 6/3/2025
Actyus Private Equity SGIIC, S.A. 13G/A Amendment 1 5.4% 5/14/2025
Event 3/31/2025
Yekaterina Chudnovsky 13D/A Amendment 5
48.1% 3/7/2025
Event 3/5/2025
Knoll Capital Management, LLC 13G
5.2% 2/5/2025
Event 1/30/2025
Actyus Private Equity SGIIC, S.A. 13G 5.5% 1/7/2025
Event 12/8/2023

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 8 1.28 M $2.32 M
2026 Q2 65 3.92 M $15.3 M
2026 Q1 54 2.64 M $28.2 M
2025 Q4 40 2.08 M $16.6 M
2025 Q3 31 1.91 M $20.9 M
2025 Q2 24 1.45 M $11.2 M
2025 Q1 25 1.59 M $9.80 M
2024 Q4 18 454 k $2.25 M
2024 Q3 20 491 k $2.48 M
2024 Q2 22 649 k $2.68 M
2024 Q1 21 407 k $3.08 M
2023 Q4 20 333 k $2.78 M
2023 Q3 19 331 k $2.80 M
2023 Q2 16 286 k $2.71 M